Revefenacin Impurity 30
Added to RFQ
For Research & Analytical Purposes. Not for Personal use.
Packaging & Handling
Indicative product packaging is shown for visual reference. Actual packaging may vary based on pack size, quantity, storage condition and shipping requirements.
Documentation Available
Detailed specifications, certificates, and supporting documents are available upon request.
Detailed specifications, certificates, and supporting documents are available upon request.
Storage: Refer MSDS for complete information.
Hazard: Refer MSDS for complete information.
Revefenacin Impurity 30 Product Information
Revefenacin Impurity 30 is listed under Impurity and is intended for analytical research, quality control and pharmaceutical reference standard applications. It is associated with Revefenacin. The product is supplied by Clearsynth under CAT No. CS-EO-02909.
Clearsynth provides this compound for research and analytical use, with product information including CAS number, molecular formula, molecular weight and product enquiry details.
Technical Data
Product Name
Revefenacin Impurity 30
CAT No.
CS-EO-02909
HSN Code
38229010
Country of Origin
Can be shipped from India, Canada and USA
Molecular Formula
C29H31N3O5
Molecular Weight
501.6
Category
API Family
Storage Condition
Refer MSDS for complete information.
Hazard Compound
Refer MSDS for complete information.
Description
Regulatory Description
Revefenacin Impurity 30 is supplied with detailed characterization data compliant with regulatory guideline. Revefenacin Impurity 30 can be used for analytical method development, method validation (AMV), Quality Control (QC) application for Abbreviated New Drug Application (ANDA), or during commercial production of Revefenacin.
Overview
Useful research chemical for a range of applications.
Synonyms
Revefenacin Impurity 30
Application Notes
Useful research chemical for a range of applications.
Product Applications & Regulatory Search Terms
Useful product, supplier and regulatory search terms for this reference standard.